AR and Familial prostate cancer: Human prostate cancer tissues obtained from four patients with moderate (Gleason 7) tumors were combined as heterotypic recombinants with AR positive human prostate PShTert-AR myofibroblasts or AR negative PShTert-ctrl and sub-renally grafted into immunodeficient NOD-SCID mice.